SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,548,000 | -85.0% | 14,000 | -89.9% | 0.01% | -80.0% |
| Q2 2022 | $10,344,000 | +3.5% | 138,000 | +7.8% | 0.02% | +47.1% |
| Q1 2022 | $9,999,000 | +808.2% | 128,000 | +947.2% | 0.02% | +750.0% |
| Q4 2021 | $1,101,000 | -94.3% | 12,223 | -94.2% | 0.00% | -94.1% |
| Q3 2021 | $19,339,000 | +3814.8% | 209,118 | +3188.5% | 0.03% | +3300.0% |
| Q2 2021 | $494,000 | -94.6% | 6,359 | -90.2% | 0.00% | -96.0% |
| Q3 2020 | $9,142,000 | +95.4% | 65,098 | +123.1% | 0.02% | +56.2% |
| Q2 2020 | $4,678,000 | -3.5% | 29,176 | -54.7% | 0.02% | +14.3% |
| Q3 2019 | $4,850,000 | +408.4% | 64,392 | +926.2% | 0.01% | +250.0% |
| Q2 2019 | $954,000 | 0.0% | 6,275 | -21.6% | 0.00% | 0.0% |
| Q1 2019 | $954,000 | -66.4% | 8,000 | -69.2% | 0.00% | -69.2% |
| Q4 2018 | $2,837,000 | +55.0% | 26,000 | +5.3% | 0.01% | +44.4% |
| Q1 2018 | $1,830,000 | -66.9% | 24,700 | -79.7% | 0.01% | -71.9% |
| Q3 2017 | $5,523,000 | – | 121,767 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |